KPT vs. CRP, BU, GCL, SWP, ADW.A, CSW.A, BR, CNT, GLG, and HLF
Should you be buying KP Tissue stock or one of its competitors? The main competitors of KP Tissue include Ceres Global (CRP), Burcon NutraScience (BU), Colabor Group (GCL), Swiss Water Decaffeinated Coffee (SWP), Andrew Peller (ADW.A), Corby Spirit and Wine (CSW.A), Big Rock Brewery (BR), Century Global Commodities (CNT), GLG Life Tech (GLG), and High Liner Foods (HLF). These companies are all part of the "consumer defensive" sector.
Ceres Global (TSE:CRP) and KP Tissue (TSE:KPT) are both small-cap consumer defensive companies, but which is the superior stock? We will compare the two businesses based on the strength of their earnings, community ranking, risk, valuation, profitability, dividends, analyst recommendations, media sentiment and institutional ownership.
KP Tissue received 209 more outperform votes than Ceres Global when rated by MarketBeat users. Likewise, 65.44% of users gave KP Tissue an outperform vote while only 63.03% of users gave Ceres Global an outperform vote.
Ceres Global has higher revenue and earnings than KP Tissue. KP Tissue is trading at a lower price-to-earnings ratio than Ceres Global, indicating that it is currently the more affordable of the two stocks.
Ceres Global has a net margin of 0.59% compared to Ceres Global's net margin of 0.00%. KP Tissue's return on equity of 3.93% beat Ceres Global's return on equity.
69.7% of Ceres Global shares are held by institutional investors. Comparatively, 13.3% of KP Tissue shares are held by institutional investors. 0.6% of Ceres Global shares are held by insiders. Comparatively, 0.1% of KP Tissue shares are held by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock will outperform the market over the long term.
In the previous week, KP Tissue had 3 more articles in the media than Ceres Global. MarketBeat recorded 4 mentions for KP Tissue and 1 mentions for Ceres Global. KP Tissue's average media sentiment score of 0.31 beat Ceres Global's score of -0.08 indicating that Ceres Global is being referred to more favorably in the media.
Ceres Global has a beta of 0.19, meaning that its share price is 81% less volatile than the S&P 500. Comparatively, KP Tissue has a beta of 0.35, meaning that its share price is 65% less volatile than the S&P 500.
KP Tissue has a consensus target price of C$9.75, indicating a potential upside of 16.49%. Given Ceres Global's higher possible upside, analysts clearly believe KP Tissue is more favorable than Ceres Global.
Summary
Ceres Global beats KP Tissue on 10 of the 16 factors compared between the two stocks.
Get KP Tissue News Delivered to You Automatically
Sign up to receive the latest news and ratings for KPT and its competitors with MarketBeat's FREE daily newsletter.
This chart shows the number of new MarketBeat users adding KPT and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
This chart shows the average media sentiment of TSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
KP Tissue Competitors List
Related Companies and Tools
